Hospital Universitario Miguel Servet
About Hospital Universitario Miguel Servet
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Spanish Breast Cancer Research Group
25
Celgene
16
Pfizer
16
Grupo Espanol de Investigacion en Sarcomas
13
Hoffmann-La Roche
13
PETHEMA Foundation
13
Boehringer Ingelheim
9
MedSIR
9
Ipsen
8
Grupo Espanol de Tumores Neuroendocrinos
7
Spanish Lung Cancer Group
7
Clinical Trials at Hospital Universitario Miguel Servet
During the past decade, Hospital Universitario Miguel Servet conducted 245 clinical trials. In the 10-year time frame, 245 clinical trials started and 79 clinical trials were completed, i.e. on
average, 32.2% percent of trials that started reached the finish line to date. In the past 5 years, 96 clinical trials started and 46 clinical trials were completed. i.e. 47.9%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
1998-03-01
Completed
500
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-10-01
2013-04-01
Completed
460
Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer
2001-11-01
2015-06-01
Completed
5,099
"OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV Subjects
2005-01-01
2007-05-01
Completed
200
Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer Patients
2001-08-01
2014-10-01
Completed
103
Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer Patients
2003-03-01
2015-01-01
Completed
46
FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients
2003-09-19
2013-10-01
Completed
1,925
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital Universitario Miguel Servet" #1 sponsor was "Spanish Breast Cancer Research Group" with 25 trials, followed by "Celgene" with 16 trials
sponsored, "Pfizer" with 16 trials sponsored, "Grupo Espanol de Investigacion en Sarcomas" with 13 trials sponsored and "Hoffmann-La Roche"
with 13 trials sponsored. Other sponsors include 329 different institutions and
companies that sponsored additional 198 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Miguel Servet"
#1 collaborator was "Hoffmann-La Roche" with 13 trials as a collaborator, "Pfizer" with 12 trials as a collaborator, "Hospital Miguel Servet" with 9 trials as a collaborator, "Apices Soluciones S.L." with 6 trials as a collaborator and "AstraZeneca" with 6 trials as a collaborator. Other collaborators include 348 different institutions and companies that were
collaborators in the rest 283 trials.
Clinical Trials Conditions at Hospital Universitario Miguel Servet
According to Clinical.Site data, the most researched conditions in "Hospital Universitario Miguel Servet" are
"Breast Cancer" (29 trials), "Crohn Disease" (10 trials), "Multiple Myeloma" (10 trials), "Metastatic Breast Cancer" (8 trials) and "Breast Neoplasms" (7 trials). Many other conditions were trialed in "Hospital Universitario Miguel Servet" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Universitario Miguel Servet
Most popular intervention types in "Hospital Universitario Miguel Servet" are "Drug" (299 trials), "Other" (48 trials), "Procedure" (25 trials), "Device" (24 trials) and "Biological" (19 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (55 trials), "Capecitabine" (13 trials), "Paclitaxel" (13 trials), "Gemcitabine" (12 trials) and "Carboplatin" (10 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Universitario Miguel Servet
The vast majority of trials in "Hospital Universitario Miguel Servet" are
353 trials for "All" genders, 54 trials for "Female" genders and 10 trials for "Male" genders.
Clinical Trials Status at Hospital Universitario Miguel Servet
Currently, there are 143 active trials in "Hospital Universitario Miguel Servet".
3 are not yet recruiting,
78 are recruiting,
61 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 217 completed trials in Hospital Universitario Miguel Servet,
undefined suspended trials,
and 35 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Universitario Miguel Servet, 21 "Phase 1"
clinical trials were conducted, 118 "Phase 2" clinical
trials and 151 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 29 trials, and there were
also 24 trials that are defined as “Not Applicable".